You just read:

Purdue Pharma L.P. Submits NDA for Once-Daily Hydrocodone Bitartrate Extended-Release Tablets Formulated to Incorporate Abuse-Deterrent Properties

News provided by

Purdue Pharma L.P.

Apr 30, 2014, 08:16 ET